The Mycobacterial DNA Methyltransferase HsdM Decreases Intrinsic Isoniazid Susceptibility

Tuberculosis, caused by the pathogen <i>Mycobacterium tuberculosis</i>, is a serious infectious disease worldwide. Multidrug-resistant TB (MDR-TB) remains a global problem, and the understanding of this resistance is incomplete. Studies suggested that DNA methylation promotes bacterial a...

Full description

Saved in:
Bibliographic Details
Main Authors: Xinling Hu (Author), Xintong Zhou (Author), Tong Yin (Author), Keyu Chen (Author), Yongfei Hu (Author), Baoli Zhu (Author), Kaixia Mi (Author)
Format: Book
Published: MDPI AG, 2021-10-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_5a4e3e3d19f749f49e728f981d6312e9
042 |a dc 
100 1 0 |a Xinling Hu  |e author 
700 1 0 |a Xintong Zhou  |e author 
700 1 0 |a Tong Yin  |e author 
700 1 0 |a Keyu Chen  |e author 
700 1 0 |a Yongfei Hu  |e author 
700 1 0 |a Baoli Zhu  |e author 
700 1 0 |a Kaixia Mi  |e author 
245 0 0 |a The Mycobacterial DNA Methyltransferase HsdM Decreases Intrinsic Isoniazid Susceptibility 
260 |b MDPI AG,   |c 2021-10-01T00:00:00Z. 
500 |a 10.3390/antibiotics10111323 
500 |a 2079-6382 
520 |a Tuberculosis, caused by the pathogen <i>Mycobacterium tuberculosis</i>, is a serious infectious disease worldwide. Multidrug-resistant TB (MDR-TB) remains a global problem, and the understanding of this resistance is incomplete. Studies suggested that DNA methylation promotes bacterial adaptability to antibiotic treatment, but the role of mycobacterial HsdM in drug susceptibility has not been explored. Here, we constructed an inactivated <i>Mycobacterium bovis</i> (BCG) strain, Δ<i>hsdM</i>. Δ<i>hsdM</i> shows growth advantages over wild-type BCG under isoniazid treatment and hypoxia-induced stress. Using high-precision PacBio single-molecule real-time sequencing to compare the Δ<i>hsdM</i> and BCG methylomes, we identified 219 methylated HsdM substrates. Bioinformatics analysis showed that most HsdM-modified genes were enriched in respiration- and energy-related pathways. qPCR showed that HsdM-modified genes directly affected their own transcription, indicating an altered redox regulation. The use of the latent Wayne model revealed that Δ<i>hsdM</i> had growth advantages over wild-type BCG and that HsdM regulated <i>trcR</i> mRNA levels, which may be crucial in regulating transition from latency to reactivation. We found that HsdM regulated corresponding transcription levels via gene methylation; thus, altering the mycobacterial redox status and decreasing the bacterial susceptibility to isoniazid, which is closely correlated with the redox status. Our results provide valuable insight into DNA methylation on drug susceptibility. 
546 |a EN 
690 |a DNA methyltransferase 
690 |a HsdM 
690 |a isoniazid 
690 |a <i>Mycobacterium bovis</i> BCG 
690 |a drug susceptibility 
690 |a Therapeutics. Pharmacology 
690 |a RM1-950 
655 7 |a article  |2 local 
786 0 |n Antibiotics, Vol 10, Iss 11, p 1323 (2021) 
787 0 |n https://www.mdpi.com/2079-6382/10/11/1323 
787 0 |n https://doaj.org/toc/2079-6382 
856 4 1 |u https://doaj.org/article/5a4e3e3d19f749f49e728f981d6312e9  |z Connect to this object online.